Account
MediaCom wins media mandate for Vivo India
MUMBAI: Handset maker Vivo has awarded its media duties to GroupM’s media agency MediaCom. The account is estimated to be worth Rs 400 crore.
The account will be managed and supervised from the MediaCom Gurgaon office.
MediaCom won the mandate following a competitive multi-agency pitch.
Vivo is today among one of the largest mobile phone brands in India.
As the full form AoR for VIVO in India, MediaCom will be responsible for the media strategy, planning, buying and implementation for all mass media. This big win follows MediaCom’s stellar showing at the Cannes Lions 2018.
Vivo India CMO Jerome Chen says, “We understand that being creative is as important for a brand as its product innovation. MediaCom’s creative ideas and approach resonate with Vivo’s ethos as an innovation-driven brand. As we continue to grow stronger in India, we believe this partnership will enable us to step up our engagement with the consumers even more. We look forward to a long and mutually successful partnership with MediaCom.”
MediaCom South Asia CEO Navin Khemka adds, “The growth of the telecom industry in India is unprecedented and the smartphone adoption brings exciting opportunities. Vivo is one of the leading and innovative players in this space. We are delighted to partner with Vivo and looking forward to creating unmatched brand value and innovative solutions for our consumers.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
